⌘K
Loading ticker…
Mesa Laboratories Inc · Healthcare · Measuring & Control Equipment
As of 2026-06-26, Mesa Laboratories Inc (MLAB) has a 3-month relative strength percentile of 77 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.8%, relative volume 1.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 77, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
MLAB is in a stage 2 uptrend, week 1. Currently in a 15-day base; basing ADR 5.7% (broad 5.3%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 0.5% / 19.4%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
MLAB is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $15M notional. Top 3 carry $31M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $15M |
| IWMiShares Russell 2000 ETF | 0.02% | $11M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| IWOiShares Russell 2000 Growth ETF | 0.03% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $627K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MLAB Jan avg: 2.31% median: 2.37% win: 75% σ: 12.20% n: 4 2022-04-12 → 2026-05-29 | MLAB Feb avg: 8.44% median: 10.20% win: 75% σ: 15.07% n: 4 2022-04-12 → 2026-05-29 | MLAB Mar avg: -5.96% median: -4.73% win: 25% σ: 7.11% n: 4 2022-04-12 → 2026-05-29 | MLAB Apr avg: -2.18% median: -3.33% win: 20% σ: 9.50% n: 5 2022-04-12 → 2026-05-29 | MLAB May avg: -8.95% median: -9.79% win: 20% σ: 9.47% n: 5 2022-04-12 → 2026-05-29 | MLAB Jun avg: -4.75% median: -4.45% win: 0% σ: 3.84% n: 4 2022-04-12 → 2026-05-29 (current) | MLAB Jul avg: 4.46% median: 2.34% win: 75% σ: 20.96% n: 4 2022-04-12 → 2026-05-29 | MLAB Aug avg: -0.78% median: 0.01% win: 50% σ: 17.64% n: 4 2022-04-12 → 2026-05-29 | MLAB Sep avg: -12.06% median: -10.22% win: 0% σ: 12.25% n: 4 2022-04-12 → 2026-05-29 | MLAB Oct avg: -5.43% median: -8.41% win: 25% σ: 8.86% n: 4 2022-04-12 → 2026-05-29 | MLAB Nov avg: 8.30% median: 7.14% win: 75% σ: 15.58% n: 4 2022-04-12 → 2026-05-29 | MLAB Dec avg: 7.86% median: 5.41% win: 50% σ: 12.04% n: 4 2022-04-12 → 2026-05-29 |